Related Experiment Videos

[Infantile fibrosarcoma: a clinicopathological and molecular study of five cases]

K Mrad1, P Dubus, F Bougrine

  • 1Service d'anatomie et cytologie pathologiques, Institut Salah Azaiez, Bab Saadoun, 1006 Tunis.

Annales De Pathologie
|February 20, 2002
PubMed

Insights

Infantile fibrosarcoma, a congenital tumor in infants, typically presents in extremities and shows a favorable prognosis with surgical treatment. Histological analysis and detection of ETV6-NK3 gene fusion aid in diagnosis.

Area of Science:

  • Pediatric Oncology
  • Surgical Pathology
  • Molecular Diagnostics

Background:

  • Infantile fibrosarcoma is a rare soft tissue tumor affecting newborns and infants.
  • Congenital presentation is common, often involving the extremities.

Observation:

  • A cohort of 5 infantile fibrosarcoma cases (4 male, 1 female) with a mean age of 5.7 months was analyzed.
  • Tumors were congenital in 4 cases and presented in the extremities (forearm, hand, thigh, lower leg).
  • Histological features included dense monotonous cells in a fascicular pattern, high mitotic index (8/10 HPF), necrosis, and lymphocytes.

Findings:

  • Surgical treatment (amputation or local excision) resulted in a favorable outcome in all cases, with follow-up ranging from 5 to 21 years.
  • ETV6-NK3 chimeric RNA was detected in 2 out of 4 tested cases using reverse transcriptase polymerase chain reaction on paraffin-embedded tissues.
  • The study highlights specific histological characteristics and the ETV6-NK3 gene fusion as diagnostic markers.

Implications:

  • Infantile fibrosarcoma demonstrates a good prognosis, emphasizing the importance of timely surgical intervention.
  • The identification of the ETV6-NK3 gene fusion provides a molecular marker for diagnosis and potentially targeted therapies.
  • Understanding these features aids in accurate diagnosis and management of infantile fibrosarcoma.

Related Concept Videos